Skip to content

Merit Medical Systems MMSI Free cash flow yield

Free cash flow yield at other companies

Abbott logo
AbbottABT
4.1%+1.2pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
7.8%
TFX
TeleflexTFX
2.7%-0.5pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
3%-2.1pp
Stryker logo
StrykerSYK
3.6%+1.1pp
Boston Scientific logo
Boston ScientificBSX
3.7%+1.7pp

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Calculated from Merit Medical Systems’s reported figures.

Based on trailing twelve months.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's free cash flow yield?
Merit Medical Systems (MMSI) reported free cash flow yield of 5.4% in Q1 2026.
How has Merit Medical Systems's free cash flow yield changed year-over-year?
Merit Medical Systems's free cash flow yield increased by 85.6% year-over-year, from 2.9% to 5.4%.
What is the long-term trend for Merit Medical Systems's free cash flow yield?
Over 5 years (2020 to 2025), Merit Medical Systems's free cash flow yield has grown at a 1.6% compound annual growth rate (CAGR), from 3.8% to 4.1%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.